HCP (HCP) was Reiterated by Mizuho to “Neutral” according to the research note released today. The brokerage firm has raised the Price Target to $ 37 from a previous price target of $32 . Mizuho advised their investors in a research report released on Aug 10, 2016.
Many Wall Street Analysts have commented on HCP. HCP was Initiated by Raymond James to “Underperform” on Jul 26, 2016. HCP was Upgraded by Goldman to ” Neutral” on Jul 8, 2016. HCP was Downgraded by Morgan Stanley to ” Underweight” on Jun 22, 2016.
On the company’s financial health, HCP reported $0.71 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 9, 2016. Analyst had a consensus of $0.70. The company had revenue of $662.20 million for the quarter, compared to analysts expectations of $623.74 million. The company’s revenue was up 9.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.79 EPS.
HCP opened for trading at $38.44 and hit $38.68 on the upside on Monday, eventually ending the session at $38.44, with a gain of 0.08% or 0.03 points. The heightened volatility saw the trading volume jump to 20,26,001 shares. Company has a market cap of $17,955 M.
In a different news, on May 11, 2016, Kai Hsiao (Executive Vice President) sold 266 shares at $36.04 per share price. According to the SEC, on Feb 17, 2016, John D. Stasinos (Executive Vice President) purchased 400 shares at $26.24 per share price. On Feb 16, 2016, Troy E. Mchenry (EVP, Gen Counsel and Corp Sec) purchased 1,000 shares at $25.75 per share price, according to the Form-4 filing with the securities and exchange commission.
HCP Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing post-acute/skilled nursing life science medical office and hospital. Its portfolio includes owned portfolio unconsolidated joint ventures and developments and redevelopments. Its owned portfolio includes around 1040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing life science and medical office segments. It has assets under development redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments which are under development or redevelopment include Pacific Corporate Park Memorial Hermann Sky Ridge Bayfront Folsom and Deer Park.